InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Browse the full record of transactions filed by Daly David, Director. Officer active across 1 company, notably Neogenomics INC. Cumulatively, 2 filings have been logged. Activity tracked since 10 November 2021. The latest transaction was disclosed on 10 June 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
2 of 2 declarations
David Daly is a Director at NEOGENOMICS INC. In this role, he participates in the governance of the company and contributes to strategic decision-making. His experience and skills are essential for guiding the company in its development and growth.